✦ LIBER ✦

Antibody-based Therapeutics for the Treatment of Human B cell Malignancies

✍ Scribed by Sivasubramanian Baskar, Natarajan Muthusamy

Book ID: 118819377
Publisher: Current Science Inc.
Year: 2012
Tongue: English
Weight: 297 KB
Volume: 13
Category: Article
ISSN: 1529-7322
DOI: 10.1007/s11882-012-0327-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Myb targeted therapeutics for the treatm

Myb targeted therapeutics for the treatment of human malignancies

✍ Gewirtz, Alan M 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 156 KB

Antibody-Drug Conjugates and Immunotoxin

Antibody-Drug Conjugates and Immunotoxins || Antibody–Drug Conjugates for the Treatment of B-Cell Malignancies

✍ Phillips, Gail Lewis 📂 Article 📅 2012 🏛 Springer New York 🌐 English ⚖ 267 KB

This volume gathers the leading research on antibody-drug conjugates and immunotoxins. Following a rigorous overview, the volume delves into focused sections on all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies.

Ofatumumab, the first human anti-CD20 mo

Ofatumumab, the first human anti-CD20 monoclonal antibody for the treatment of B cell hematologic malignancies

✍ Ira V. Gupta; Roxanne C. Jewell 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 602 KB

Lenalidomide for the Treatment of B-Cell

Lenalidomide for the Treatment of B-Cell Malignancies

✍ Chanan-Khan, A. A.; Cheson, B. D. 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 226 KB

Ofatumumab, a Novel Anti-CD20 Monoclonal

Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies

✍ Cheson, B. D. 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 234 KB

The therapeutic use of antibodies for ma

The therapeutic use of antibodies for malignancy

✍ P.W.M Johnson 📂 Article 📅 2001 🏛 Elsevier Science 🌐 French ⚖ 81 KB